Shares of ESSA Pharma Inc. (NASDAQ:EPIX – Get Free Report) (TSE:EPI) passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $5.52 and traded as high as $6.44. ESSA Pharma shares last traded at $6.21, with a volume of 26,521 shares.
ESSA Pharma Trading Up 3.7 %
The firm has a 50-day moving average of $5.56 and a 200 day moving average of $6.20. The stock has a market capitalization of $285.70 million, a price-to-earnings ratio of -10.22 and a beta of 1.84.
ESSA Pharma (NASDAQ:EPIX – Get Free Report) (TSE:EPI) last issued its quarterly earnings data on Monday, August 5th. The company reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.10. Equities research analysts predict that ESSA Pharma Inc. will post -0.71 EPS for the current fiscal year.
Institutional Trading of ESSA Pharma
About ESSA Pharma
ESSA Pharma Inc, a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer.
Featured Articles
- Five stocks we like better than ESSA Pharma
- Stock Market Upgrades: What Are They?
- CarMax’s Impressive Rally: What Investors Should Watch Next
- How to invest in marijuana stocks in 7 steps
- MarketBeat Week in Review – 9/23 – 9/27
- 3 Stocks to Consider Buying in October
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for ESSA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ESSA Pharma and related companies with MarketBeat.com's FREE daily email newsletter.